Terms: = Sarcomas AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
5 results:
1. CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Schroeder BA; LaFranzo NA; LaFleur BJ; Gittelman RM; Vignali M; Zhang S; Flanagan KC; Rytlewski J; Riolobos L; Schulte BC; Kim TS; Chen E; Smythe KS; Wagner MJ; Mantilla JG; Campbell JS; Pierce RH; Jones RL; Cranmer LD; Pollack SM
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34465597
[TBL] [Abstract] [Full Text] [Related]
2. Current status of immunotherapy for sarcomas.
Miwa S; Nishida H; Tsuchiya H
Immunotherapy; 2017 Dec; 9(16):1331-1338. PubMed ID: 29185391
[TBL] [Abstract] [Full Text] [Related]
3. Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
Di Giacomo AM; Ascierto PA; Queirolo P; Pilla L; Ridolfi R; Santinami M; Testori A; Simeone E; Guidoboni M; Maurichi A; Orgiano L; Spadola G; Del Vecchio M; Danielli R; Calabrò L; Annesi D; Giannarelli D; Maccalli C; Fonsatti E; Parmiani G; Maio M
Ann Oncol; 2015 Apr; 26(4):798-803. PubMed ID: 25538176
[TBL] [Abstract] [Full Text] [Related]
4. CD9 expression is not a prognostic factor in human osteosarcoma.
Kubista B; Erovic BM; Klinger H; Sulzbacher I; Trieb K
Cancer Lett; 2004 Jun; 209(1):105-10. PubMed ID: 15145525
[TBL] [Abstract] [Full Text] [Related]
5. [Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Hibi S; Naya M; Takaya K; Morimoto M; Kataoka Y; Todo S; Imashuku S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1249-52. PubMed ID: 8333754
[TBL] [Abstract] [Full Text] [Related]
